SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 263 filers reported holding SAGE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $30,590,000 | -9.9% | 353,603 | -36.3% | 0.18% | -17.3% |
| Q3 2020 | $33,951,000 | +45.2% | 555,473 | -1.2% | 0.22% | +36.6% |
| Q2 2020 | $23,387,000 | +90.8% | 562,457 | +31.8% | 0.16% | +49.1% |
| Q1 2020 | $12,255,000 | -31.3% | 426,692 | +72.6% | 0.11% | -15.0% |
| Q4 2019 | $17,846,000 | -13.4% | 247,209 | +68.2% | 0.13% | -23.0% |
| Q3 2019 | $20,617,000 | – | 146,961 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |